Unraveling the NLRP family: Structure, function, activation, critical influence on tumor progression, and potential as targets for cancer therapy
Related Experiment Video
Updated: Jun 11, 2025

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
Xueqing Zhou1, Yongguang Tao1, Ying Shi1
1Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, 410013, China; Cancer Research Institute and School of Basic Medicine, Central South University, Changsha, Hunan, 410013, China.
Abstract:
The innate immune system serves as the body's initial defense, swiftly detecting danger via pattern recognition receptors (PRRs). Among these, nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing proteins (NLRPs) are pivotal in recognizing pathogen-associated and damage-associated molecular patterns, thereby triggering immune responses. NLRPs, the most extensively studied subset within the NLR family, form inflammasomes that regulate inflammation, essential for innate immunity activation. Recent research highlights NLRPs' significant impact on various human diseases, including cancer. With differential expression across organs, NLRPs influence cancer progression by modulating immune reactions, cell fate, and proliferation. Their clinical significance in cancer makes them promising therapeutic targets. This review provides a comprehensive overview of the structure, function, activation mechanism of the NLRPs family and its potential role in cancer progression. In addition, we particularly focused on the concept of NLRP as a therapeutic target and its potential value in combination with immune checkpoint inhibitors.
Insights
Nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing proteins (NLRPs) are crucial for innate immunity and cancer progression. Targeting NLRPs offers a promising therapeutic strategy, potentially enhancing immune checkpoint inhibitor efficacy.
Area of Science:
- Immunology
- Oncology
Background:
- The innate immune system relies on pattern recognition receptors (PRRs) for initial defense.
- Nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing proteins (NLRPs) are key PRRs that form inflammasomes, regulating inflammation and innate immunity.
Purpose of the Study:
- To provide a comprehensive overview of NLRP structure, function, and activation mechanisms.
- To explore the role of NLRPs in cancer progression and their potential as therapeutic targets.
Main Methods:
- Literature review focusing on NLRPs' role in immunity and cancer.
- Analysis of NLRPs' differential expression and impact on cancer hallmarks.
- Examination of NLRPs as therapeutic targets, including combination strategies with immune checkpoint inhibitors.
Main Results:
- NLRPs are significantly implicated in various human cancers.
- NLRPs influence cancer progression by modulating immune responses, cell fate, and proliferation.
- NLRPs represent promising therapeutic targets in oncology.
Conclusions:
- NLRPs play a critical role in both innate immunity and cancer development.
- Targeting NLRPs may offer novel therapeutic avenues for cancer treatment.
- Combining NLRP-targeted therapies with immune checkpoint inhibitors shows potential clinical value.
More Related Videos
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
07:39Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Related Concept Videos
lncRNA - Long Non-coding RNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway
The Ras Gene
Ras is a...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...